Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FVC”

47 trials

Showing 20 of 47 results

Not applicableStudy completedNCT03898284
What this trial is testing

Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 54
Not applicableLooking for participantsNCT07257302
What this trial is testing

Lung Insufflation Capacity Training and Respiratory Function in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
National Center of Neurology and Psychiatry, Japan 15
Not applicableStudy completedNCT03534557
What this trial is testing

FEV1/FEV6 and FEV6 as an Alternative for FEV1/FVC and FVC in Bolivian Subjects

Who this might be right for
Copd
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableStudy completedNCT04702893
What this trial is testing

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 108
Testing effectiveness (Phase 2)Study completedNCT00514683
What this trial is testing

Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 432
Early research (Phase 1)Study completedNCT01640067
What this trial is testing

Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Ospedaliera Santa Maria, Terni, Italy 18
Early research (Phase 1)Study completedNCT00580593
What this trial is testing

Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Michigan 60
Not applicableUnknownNCT05145088
What this trial is testing

Association Analysis of Aerobic Capacity and Expiratory Forced Vital Capacity in Overweight and Obese Adults After Submaximal Exercise Training of Three Weeks

Who this might be right for
Overweight and Obese Adults
Foundation University Islamabad 30
Large-scale testing (Phase 3)Study completedNCT03208933
What this trial is testing

Open-label Study to Assess the Effectiveness of Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis (IPF).

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 60
Large-scale testing (Phase 3)Looking for participantsNCT04965298
What this trial is testing

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

Who this might be right for
Idiopathic Pulmonary Fibrosis
Norfolk and Norwich University Hospitals NHS Foundation Trust 298
Testing effectiveness (Phase 2)Ended earlyNCT06317285
What this trial is testing

Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
GlaxoSmithKline 158
Not applicableStudy completedNCT04674943
What this trial is testing

Breathing Exercises in Asthma During Pregnancy

Who this might be right for
Asthma in Pregnancy
Riphah International University 24
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110
Testing effectiveness (Phase 2)Study completedNCT07035561
What this trial is testing

Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis

Who this might be right for
Hypersenstivity PneumonitisILD
Shereen Medhat Mohammed Elsayed Nassar 30
Not applicableStudy completedNCT07126691
What this trial is testing

" ISynchroızed Swımmıng And Free Style Swımmıng

Who this might be right for
Healthy Young Children
Yeditepe University 24
Testing effectiveness (Phase 2)Looking for participantsNCT06470048
What this trial is testing

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals 200
Not applicableStudy completedNCT03161587
What this trial is testing

Patient Characteristics and Treatment Modalities in COPD Patients in China

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 848
Not applicableLooking for participantsNCT06751537
What this trial is testing

Effectiveness of the WearME System for COPD Severity and Respiratory Function

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
LASARRUS Clinic and Research Center 128
Testing effectiveness (Phase 2)Looking for participantsNCT06655896
What this trial is testing

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Diffuse
Novartis Pharmaceuticals 96
Post-approval studies (Phase 4)UnknownNCT01131806
What this trial is testing

Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Taipei Veterans General Hospital, Taiwan 124
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation